Web-Based Harm Reduction Intervention for Chemsex in Men Who Have Sex With Men: Randomized Controlled Trial.

Edmond Pui Hang Choi, Kitty Wai Ying Choi, Chanchan Wu, Pui Hing Chau, Jojo Yan Yan Kwok, William Chi Wai Wong, Eric Pui Fung Chow
Author Information
  1. Edmond Pui Hang Choi: School of Nursing, The University of Hong Kong, Hong Kong, China (Hong Kong). ORCID
  2. Kitty Wai Ying Choi: School of Nursing, The University of Hong Kong, Hong Kong, China (Hong Kong). ORCID
  3. Chanchan Wu: School of Nursing, The University of Hong Kong, Hong Kong, China (Hong Kong). ORCID
  4. Pui Hing Chau: School of Nursing, The University of Hong Kong, Hong Kong, China (Hong Kong). ORCID
  5. Jojo Yan Yan Kwok: School of Nursing, The University of Hong Kong, Hong Kong, China (Hong Kong). ORCID
  6. William Chi Wai Wong: Department of Family Medicine and Primary Care, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong). ORCID
  7. Eric Pui Fung Chow: Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia. ORCID

Abstract

BACKGROUND: Men who have sex with men (MSM) who practice chemsex have a higher likelihood of engaging in risky sexual behaviors and higher rates of HIV infection and other sexually transmitted infections (STIs) than those who do not.
OBJECTIVE: This trial aimed to evaluate the effectiveness of a web-based intervention in reducing the sexual harms of chemsex among MSM.
METHODS: The study was a 2-arm, assessor-blinded, randomized, parallel-group trial with a 3-month follow-up period. The study was conducted in the year 2021 in Hong Kong. Underpinned by the theory of planned behaviors and a harm reduction approach, the intervention consisted of interactive components and knowledge-based information about chemsex. Participants in the control group received brief information and content about sexual violence. The primary outcome was self-efficacy in refusing risky sexual behaviors and chemsex, as measured by the Condom Self-Efficacy Scale (CSES), Self-Efficacy for Sexual Safety (SESS) instrument, and Drug Avoidance Self-Efficacy Scale (DASES). The secondary outcomes included intentions to have chemsex, actual engagement in chemsex, HIV and other STI testing, and condom use in the last 3 months. All outcomes were self-reported. An online structured questionnaire was used to collect data.
RESULTS: In total, 316 MSM enrolled in the study. The intervention group demonstrated a significantly larger improvement in condom-use self-efficacy (as measured by CSES scores; time-by-group interaction: β=4.52, 95% CI 2.03-7.02; P<.001), self-efficacy for sexual safety (as measured by SESS scores; time-by-group interaction: β=2.11, 95% CI 0.66-3.56; P=.004), and drug avoidance self-efficacy (as measured by DASES scores; time-by-group interaction: β=6.98, 95% CI 1.75-12.22; P=.009). Regarding the secondary outcomes, participants in the intervention group demonstrated a significantly larger reduction in the likelihood of having engaged in chemsex in the last 3 months (time-by-group interaction: odds ratio [OR]=0.23, 95% CI 0.10-0.53; P=.001) and likelihood of having had the intention to engage in chemsex in the last 3 months (time-by-group interaction: OR=0.37, 95% CI 0.18-0.78; P=.009). Participants in the intervention group also showed a significantly larger increase in the likelihood of having undergone HIV testing in the last 3 months (time-by-group interaction: OR=3.08, 95% CI 1.72-5.54; P<.001).
CONCLUSIONS: This study suggests that a web-based intervention with a harm reduction approach can enhance the self-efficacy of MSM in refusing risky sexual behaviors and chemsex and improve the uptake of HIV testing. We also provide initial evidence that such interventions can reduce both the intention of MSM to engage in chemsex and their actual engagement in chemsex.
TRIAL REGISTRATION: ISRCTN Registry ISRCTN20134522; https://www.isrctn.com/ISRCTN20134522.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1186/s12889-021-10742-8.

Keywords

Associated Data

ISRCTN | ISRCTN20134522

References

  1. J Med Internet Res. 2020 May 25;22(5):e15977 [PMID: 32449685]
  2. BMC Public Health. 2021 Apr 13;21(1):713 [PMID: 33849517]
  3. Aust N Z J Public Health. 2021 Dec;45(6):622-627 [PMID: 34473388]
  4. J Med Internet Res. 2014 May 26;16(5):e134 [PMID: 24862459]
  5. BMC Public Health. 2020 Nov 25;20(1):1785 [PMID: 33238948]
  6. Sex Transm Infect. 2015 Dec;91(8):564-8 [PMID: 26163510]
  7. AIDS Behav. 2019 Sep;23(9):2253-2272 [PMID: 31401741]
  8. HIV Med. 2018 May 22;: [PMID: 29790254]
  9. Sex Health. 2018 Apr;15(2):151-156 [PMID: 29580377]
  10. Prev Med Rep. 2020 Mar 06;18:101074 [PMID: 32226730]
  11. Curr HIV/AIDS Rep. 2019 Jun;16(3):244-256 [PMID: 31183609]
  12. Annu Rev Biomed Eng. 2013;15:359-82 [PMID: 23683088]
  13. Int J Drug Policy. 2017 May;43:33-43 [PMID: 28189979]
  14. J Med Internet Res. 2021 Apr 23;23(4):e22477 [PMID: 33890855]
  15. Sex Health. 2022 Apr;19(2):127-131 [PMID: 35437141]
  16. Lancet Public Health. 2021 Jul;6(7):e528-e533 [PMID: 34087117]
  17. N Engl J Med. 2010 Dec 30;363(27):2587-99 [PMID: 21091279]
  18. Int J Drug Policy. 2019 Jan;63:74-89 [PMID: 30513473]
  19. Perspect Public Health. 2019 Jan;139(1):23-33 [PMID: 29846139]
  20. Dialogues Clin Neurosci. 2022 Jun 1;23(1):39-43 [PMID: 35860173]
  21. Int J Environ Res Public Health. 2020 Dec 04;17(23): [PMID: 33291855]
  22. Int J Infect Dis. 2018 Dec;77:113-117 [PMID: 30395980]
  23. J Sex Res. 2021 Jul;58(6):785-794 [PMID: 33656408]
  24. Sex Transm Infect. 2015 Feb;91(1):14-20 [PMID: 25433051]
  25. AIDS Behav. 2021 Aug;25(8):2657-2660 [PMID: 33745099]
  26. Curr HIV/AIDS Rep. 2020 Oct;17(5):422-430 [PMID: 32725317]
  27. Lancet HIV. 2022 Oct;9(10):e717-e725 [PMID: 35926550]
  28. J Med Internet Res. 2020 Jul 24;22(7):e17894 [PMID: 32706705]
  29. PLoS One. 2018 Feb 12;13(2):e0191671 [PMID: 29432470]
  30. AIDS Educ Prev. 2016 Dec;28(6):499-510 [PMID: 27925485]
  31. JBI Database System Rev Implement Rep. 2019 Jun;17(6):1026-1033 [PMID: 31082938]
  32. J Sex Med. 2019 May;16(5):721-732 [PMID: 30952548]
  33. Int J Environ Res Public Health. 2021 Jan 15;18(2): [PMID: 33467770]
  34. Sex Transm Infect. 2022 Dec;98(8):549-556 [PMID: 35039437]
  35. J Subst Abuse. 1995;7(2):151-63 [PMID: 7580226]
  36. Sex Transm Dis. 2018 May;45(5):325-331 [PMID: 29465683]
  37. AIDS Behav. 2011 Aug;15(6):1171-9 [PMID: 20217471]
  38. BMJ. 2015 Nov 03;351:h5790 [PMID: 26537832]
  39. Front Psychiatry. 2020 Nov 04;11:542301 [PMID: 33329083]

MeSH Term

Male
Humans
Homosexuality, Male
HIV Infections
Harm Reduction
Internet-Based Intervention
Sexual and Gender Minorities
Sexually Transmitted Diseases

Word Cloud

Created with Highcharts 10.0.0chemsexsexualinterventiontime-by-groupinteraction:95%CIMSMself-efficacylikelihoodbehaviorsHIVstudygroupmeasuredlast3monthsP=menriskytrialreductionSelf-Efficacyoutcomestestingsignificantlylargerscores0010Mensexhigherweb-basedharmapproachinformationParticipantsrefusingScaleCSESSESSDASESsecondaryactualengagementdemonstratedP<drug1009intentionengagealsocanBACKGROUND:practiceengagingratesinfectionsexuallytransmittedinfectionsSTIsnotOBJECTIVE:aimedevaluateeffectivenessreducingharmsamongMETHODS:2-armassessor-blindedrandomizedparallel-group3-monthfollow-upperiodconductedyear2021HongKongUnderpinnedtheoryplannedconsistedinteractivecomponentsknowledge-basedcontrolreceivedbriefcontentviolenceprimaryoutcomeCondomSexualSafetyinstrumentDrugAvoidanceincludedintentionsSTIcondomuseself-reportedonlinestructuredquestionnaireusedcollectdataRESULTS:total316enrolledimprovementcondom-useβ=452203-702safetyβ=21166-356004avoidanceβ=69875-1222Regardingparticipantsengagedoddsratio[OR]=02310-053OR=03718-078showedincreaseundergoneOR=30872-554CONCLUSIONS:suggestsenhanceimproveuptakeprovideinitialevidenceinterventionsreduceTRIALREGISTRATION:ISRCTNRegistryISRCTN20134522https://wwwisrctncom/ISRCTN20134522INTERNATIONALREGISTEREDREPORTIDENTIFIERIRRID:RR2-101186/s12889-021-10742-8Web-BasedHarmReductionInterventionChemsexSexMen:RandomizedControlledTrialChineseabuseeHealthprevention

Similar Articles

Cited By